BWAY
BrainsWay Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$14.10
−2.83%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
34.7x
EV/EBITDA
42.0x
Market Cap
$566.93M
MomentumView details →
1D Return
−2.83%
YTD Return
+47.84%
RSI (14)
41.3
ValuationView details →
P/E (Fwd)
34.7x
EV/EBITDA
42.0x
Market Cap
$566.93M
RSI (14)
41.3
MomentumView details →
1D Return
−2.83%
YTD Return
+47.84%
SummaryUpdated Jun 1, 2026
BrainsWay Ltd. (NASDAQ:BWAY) is an Israeli medical device company founded in 2003 and headquartered in Jerusalem. The company went public on NASDAQ in April 2019. BrainsWay develops and commercializes Deep Transcranial Magnetic Stimulation (Deep TMS) technology, a non-invasive neurostimulation treatment platform for various mental health and neurological disorders. The company has evolved from a research-focused startup to a profitable medical device manufacturer with over 1,350 systems installed globally and a growing presence in both domestic U.S. and international markets.
Similar companies
Latest newsMore news →